Transcatheter Aortic Valve Replacement Industry Growth Expected to Reach $9.97 Billion by 2029 at a CAGR of 14% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Transcatheter Aortic Valve Replacement Market Growth in 2025?
The market size for transcatheter aortic valve replacement has experienced a rapid expansion in the recent past. It is projected to rise from $5.19 billion in 2024 to $5.91 billion in 2025, representing a compound annual growth rate (CAGR) of 13.9%. This growth in the historical period can be linked to factors such as the escalating incidence of aortic regurgitation, an increase in cardiovascular diseases, a surge in patient preference for less invasive treatments, worldwide growth of TAVR procedures, and advantageous reimbursement policies.
What Is the Forecast for the Transcatheter Aortic Valve Replacement Market Size Through 2029?
In the upcoming years, the market size for transcatheter aortic valve replacement is projected to experience significant growth, poised to reach $9.97 billion by 2029, with a promising compound annual growth rate (CAGR) of 14.0%. The growth expected in this period can be linked to several factors – increasing incidences of aortic stenosis, rising preference for minimally invasive procedures, broadened indications for TAVR procedures, beneficial reimbursement policies, and strengthened awareness of TAVR as a feasible treatment option. Key trends influencing this growth during the forecast period include constant advancements in device technology, growing cases of cardiovascular diseases, worldwide expansion of TAVR procedures, an aging population, and increased healthcare spending.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp
What are the Key Market Players in Transcatheter Aortic Valve Replacement Market and How They’re Evolving?
Major companies operating in the transcatheter aortic valve replacement market include Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.
What Are the Primary Growth Drivers in the Transcatheter Aortic Valve Replacement Market?
The rise in instances of aortic stenosis is a contributing element in the upward trend of the transcatheter aortic valve replacement market. Aortic stenosis, which is characterized by the narrowing of the aortic valve in the heart, is a health issue that can be addressed by transcatheter aortic valve replacement (TAVR). This approach is less invasive than surgical aortic valve replacement (SAVR), helping restore blood circulation and alleviate aortic valve stenosis symptoms and signs. For example, data released by the American Heart Association, a nonprofit organization based in the US, in May 2024 demonstrated that more than 12% of older Americans are dealing with aortic stenosis, a frequent diagnosis in those over 65. Without proper treatment, this condition can lead to heart failure and even death. Similarly, in March 2023, the National Institute for Health and Care Excellence (NICE), a public entity in the UK, published a report stating that approximately 1.5% of UK individuals over 55, or about 300,000 people, suffer from severe aortic stenosis. Nearly 200,000 of these require treatment for symptomatic disease, thus leading to over 380,000 people on cardiac waiting lists by March 2023. Consequently, the surge in aortic stenosis occurrence is fueling the transcatheter aortic valve replacement market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12031&type=smp
What Are the Leading Segments in the Global Transcatheter Aortic Valve Replacement Industry?
The transcatheter aortic valve replacement market covered in this report is segmented –
1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems
What Are the Key Market Trends in the Transcatheter Aortic Valve Replacement Industry?
The spotlight in the transcatheter aortic valve replacement (TAVR) market is increasingly focusing on product innovation. Firms in the industry are taking strides to design state-of-the-art, creative solutions to solidify their market standing. Edwards Lifesciences, a medical technology firm based in the US, played a significant part in amplifying this trend when they launched the Sapien 3 Ultra Resilia valve in Europe, in May 2024. This marked the only TAVR system to implement the company’s exclusive Resilia tissue technology. With its focus on enhancing the durability of the valve, this groundbreaking technology uses bovine pericardial tissue which has undergone anti-calcification treatments. This addition of anti-calcification technology to the Resilia framework acts to counter structural valve deterioration, which is a primary trigger for reintervention post valve replacement.
Access The Full Report Here:
What Is the Regional Outlook for the Transcatheter Aortic Valve Replacement Market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12031
This Report Delivers Insight On:
1. How big is the transcatheter aortic valve replacement market, and how is it changing globally?
2. Who are the major companies in the transcatheter aortic valve replacement market, and how are they performing?
3. What are the key opportunities and risks in the transcatheter aortic valve replacement market right now?
4. Which products or customer segments are growing the most in the transcatheter aortic valve replacement market?
5. What factors are helping or slowing down the growth of the transcatheter aortic valve replacement market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
